Výsledky vyhledávání - "B. Holowiecka"

2-Chlorodeoxyadenosine treatment in non-Hodgkin's Lymphoma and B-cell chronic lymphocytic leukemia resistant to conventional chemotherapy: results of a multicentric experience

Autor: Jerzy Holowiecki, Anna Dmoszynska, Maura Brugiatelli, Boris Labar, V. Callea, Fortunato Morabito, Branimir Jakšić, Ana Planinc-Peraica, Dieter Lutz, B. Holowiecka, O. Krieger

Publikováno v: Annals of Hematology. 73:79-84

Among the purine analogs, 2-chlorodeoxyadenosine (2-CDA) is particularly effective for the treatment of hairy cell leukemia and Waldemstrom's macroglobulinemia. Both efficacy and toxicity of 2-CDA were evaluated in previously treated patients affecte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7efa4d7047c64a3dcffb6690e71fe5aa
https://doi.org/10.1007/s002770050205

Zobrazit plný text záznamu

Idarubicin, Cytarabine, Etoposide Versus Risk-Adjusted Daunorubicin Plus Cytosine Arabinoside for Induction Treatment of Acute Myeloid Leukemia: A Randomized Multicenter Trial

Autor: Lech Konopka, A. Skotnicki, Z. Kuratowska, Stanisław Maj, M. Krawcyzk, Andrzej Hellmann, Anna Dmoszynska, Rudzka E, J. Holowiecki, B. Holowiecka, S. Krzemien, E. Krykowski

Publikováno v: Acute Leukemias VI ISBN: 9783642643798

The aim of study was to evaluate the efficacy and tolerability of the the idarubicin, cytarabine (ara-C), and etoposide (ICE) remission induction protocol in comparison to the modified, risk-adjusted daunorubicin(DNR) and ara-C (DA) schedule. Fifty-s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5572b29b3186a8ec555f076c6c225cf6
https://doi.org/10.1007/978-3-642-60377-8_127

Zobrazit plný text záznamu

2-Chlorodeoxyadenosine treatment in non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia resistant to conventional chemotherapy: results of a multicentric experience. International Society for Chemo-Immunotherapy

Autor: M, Brugiatelli, B, Holowiecka, A, Dmoszynska, O, Krieger, A, Planinc-Peraica, B, Labar, V, Callea, F, Morabito, B, Jaksic, J, Holowiecki, D, Lutz

Publikováno v: Annals of hematology. 73(2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f1e113fd1dd71793f8d83dc04a196016
https://pubmed.ncbi.nlm.nih.gov/8774616

Zobrazit plný text záznamu

Efficacy of an Original Cell Kinetics Based Chemotherapy Regimen Using rHU GM-CSF for Induction and Consolidation Treatment of ALL. Preliminary Analysis

Autor: B. Holowiecka, Holowiecki J, Cedrych I, Rudzka E, K. Jagoda, Krzemień S

Publikováno v: Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ISBN: 9783642783524

The use of intensive chemotherapy regimens has led to considerable improvement in the prognosis of adult acute lymphoblastic leukemia (ALL), but the results are still unsatisfactory with only about 30% of patients having probability of remaining cont

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7069a90dd038a0832d59181a32c033e2
https://doi.org/10.1007/978-3-642-78350-0_80

Zobrazit plný text záznamu

The evaluation of prognostic factors for achieving complete remission and survival in ANLL of adults. The proposition of a prognostic scale

Autor: S, Krzemien, J, Holowiecki, K, Jagoda, B, Holowiecka

Publikováno v: Folia haematologica (Leipzig, Germany : 1928). 117(5)

The retrospective analysis has concerned 323 patients with acute nonlymphocytic leukaemia (ANLL). The comparable patients groups were treated since 1981 according to protocols used by the Polish Acute Leukaemia Group (induction; modified TAD or Adria

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b1156a08daad660e3ca08e398a463328
https://pubmed.ncbi.nlm.nih.gov/1709908

Zobrazit plný text záznamu

Expression of CD-15 Antigen on Leukemic Cells — A New Prognostic Factor for Ability to Achieve Complete Remission and for Survival in ANLL

Autor: G. Keleney, B. Holowiecka, J. Hołowiecki, F. Graf, I. Krč, S. Krzemień, V. Callea, D. Lutz, R. Ihle, K. Jagoda, M. Brugiatelli

Publikováno v: Acute Leukemias ISBN: 9783540165569

One of the key problems in acute leukemia is the optimal treatment based on adjusted management while at the same time taking into consideration the risk factors [1]. The monoclonal antibodies (MoAbs) directed against cell differentiation antigens ha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f9662de8834e9431e6e37e30b808088e
https://doi.org/10.1007/978-3-642-71213-5_59

Zobrazit plný text záznamu

Seven day cytosine arabinoside administered subcutaneously plus daunorubicin for remission induction in AML

Autor: J, Holowiecki, E, Rudzka, K, Jarczok, B, Holowiecka, M, Krawczyk, M, Duraj, J, Japa

Publikováno v: Folia haematologica (Leipzig, Germany : 1928). 110(6)

51 patients (mean age 40, range 17-71) with previously untreated AML (25% of M4-6 FAB type) were given Ara-C subcutaneously 100 mg/m2 every 12 h for 7 days and DNR 45 mg/m2 on days 1-3 i.v. for inducing remission. After 52 days 49% of patients on an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5a49edc65ccda3ea41ac59ee802a1645
https://pubmed.ncbi.nlm.nih.gov/6200390

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání